Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
-
- Sylvain Ladoire
- 1Centre Régional de Lutte Contre le Cancer and
-
- Laurent Arnould
- 1Centre Régional de Lutte Contre le Cancer and
-
- Lionel Apetoh
- 3Institut Gustave Roussy, Villejuif, France
-
- Bruno Coudert
- 1Centre Régional de Lutte Contre le Cancer and
-
- Francois Martin
- 2Institut National de la Sante et de la Recherche Medicale CRI-866, Faculty of Medicine, Dijon, France; and
-
- Bruno Chauffert
- 1Centre Régional de Lutte Contre le Cancer and
-
- Pierre Fumoleau
- 1Centre Régional de Lutte Contre le Cancer and
-
- François Ghiringhelli
- 1Centre Régional de Lutte Contre le Cancer and
説明
<jats:title>Abstract</jats:title> <jats:p>Purpose: T-cell infiltration is associated with good tumor prognosis in many cancers. To assess the capacity of neoadjuvant chemotherapy to affect T-cell infiltration in breast cancer, we evaluated CD3 and CD8 infiltrates, and the Foxp3 immunosuppressive T cells.</jats:p> <jats:p>Experimental Design: CD3+, CD8+, and Foxp3+ cell infiltrates were detected by immunohistochemistry in a series of 56 breast cancer patients before and after the end of neoadjuvant chemotherapy.</jats:p> <jats:p>Results: Poor prognostic factors (negative hormonal receptors, high tumor grade, and nodal involvement) were associated with a significantly higher number of CD3, CD8, and Foxp3 infiltrates before the beginning of chemotherapy. Chemotherapy resulted in a decrease in Foxp3 infiltrates, whereas the level of CD8 and CD3 infiltrates remained unchanged. Pathologic complete responses (pCR) had a drastic decrease of Foxp3+ cells, whereas these cells remained elevated in nonresponders. A cutoff criterion that combined high CD8 infiltration and no Foxp3 cell infiltration on surgical specimens is associated with pCR with a sensitivity of 75% and a specificity of 93%. The infiltrate of cytotoxic TiA1 and granzyme B–positive cells was dramatically enhanced after chemotherapy only in patients with pCR. By multivariate analysis, association of a high CD8 infiltration and no Foxp3 infiltration on final histologic specimens were independently associated with pCR.</jats:p> <jats:p>Conclusion: These findings indicate that pCR to neoadjuvant chemotherapy is associated with an immunologic profile combining the absence of immunosuppressive Foxp3 cells and the presence of a high number of CD8 T cells and cytotoxic cells. These results argue for the induction of an antitumor immune response by chemotherapy.</jats:p>
収録刊行物
-
- Clinical Cancer Research
-
Clinical Cancer Research 14 (8), 2413-2420, 2008-04-15
American Association for Cancer Research (AACR)